Selective Estrogen Receptor Modulators (SERMs) can be a cornerstone of pharmaceutical PCT interventions. They perform as aggressive inhibitors at estrogen receptors while in the hypothalamus even though exhibiting tissue-selective agonist or antagonist Attributes throughout the system. SERMs are important in regulating post cycle estrogen manufactu